[1]
“A Systematic Review of Pharmacodynamics and Cardio-Renal Outcomes of SGLT-2 and DPP-4 Inhibition in Type 2 Diabetes Mellitus: Review Article”, JOPIR, vol. 4, no. 1, pp. 013–022, Feb. 2026, doi: 10.69613/45czct54.